These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2683764)

  • 1. Decreased phenytoin levels in patients receiving chemotherapy.
    Grossman SA; Sheidler VR; Gilbert MR
    Am J Med; 1989 Nov; 87(5):505-10. PubMed ID: 2683764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.
    Ghosh C; Lazarus HM; Hewlett JS; Creger RJ
    J Neurooncol; 1992 Jan; 12(1):25-32. PubMed ID: 1311752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired phenytoin bioavailability secondary to cisplatinum, vinblastine, and bleomycin.
    Sylvester RK; Lewis FB; Caldwell KC; Lobell M; Perri R; Sawchuk RA
    Ther Drug Monit; 1984; 6(3):302-5. PubMed ID: 6209833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
    Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
    J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review.
    Gattis WA; May DB
    Ann Pharmacother; 1996 May; 30(5):520-6. PubMed ID: 8740335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
    Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
    Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased phenytoin level during antineoplastic therapy: a case report.
    Bollini P; Riva R; Albani F; Ida N; Cacciari L; Bollini C; Baruzzi A
    Epilepsia; 1983 Feb; 24(1):75-8. PubMed ID: 6822234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
    Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
    Rusthoven JJ; Quirt IC; Iscoe NA; McCulloch PB; James KW; Lohmann RC; Jensen J; Burdette-Radoux S; Bodurtha AJ; Silver HK; Verma S; Armitage GR; Zee B; Bennett K
    J Clin Oncol; 1996 Jul; 14(7):2083-90. PubMed ID: 8683240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interaction between cytostatic and anticonvulsant drugs.
    Neef C; de Voogd-van der Straaten I
    Clin Pharmacol Ther; 1988 Apr; 43(4):372-5. PubMed ID: 3128415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin toxicity in a patient receiving concomitant use of phenytoin and S-1 plus cisplatin chemotherapy for advanced gastric cancer.
    Mimatsu K; Oida T; Kawasaki A; Kida K; Fukino N; Kuboi Y; Kano H; Amano S
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):1003-6. PubMed ID: 21677496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
    J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
    Quinn JA; Pluda J; Dolan ME; Delaney S; Kaplan R; Rich JN; Friedman AH; Reardon DA; Sampson JH; Colvin OM; Haglund MM; Pegg AE; Moschel RC; McLendon RE; Provenzale JM; Gururangan S; Tourt-Uhlig S; Herndon JE; Bigner DD; Friedman HS
    J Clin Oncol; 2002 May; 20(9):2277-83. PubMed ID: 11980998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.
    Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP
    Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable metabolic interaction of doxifluridine with phenytoin.
    Konishi H; Morita K; Minouchi T; Nakajima M; Matsuda M; Yamaji A
    Ann Pharmacother; 2002 May; 36(5):831-4. PubMed ID: 11978162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.